| Earnings, Trading Statements Calendar | |
| Friday, June 10 | |
| Bonmarche Holdings | Half Year Results |
| Sthree | Trading Statement |
| Fuller Smith & Turner | Full Year Results |
| Edinburgh Worldwide Investment Trust | Half Year Results |
| Monday, June 13 | |
| Establishment Investment Trust | Full Year Results |
| Schroder Real Estate Investment Trust | Full Year Results |
| Tuesday, June 14 | |
| Ashtead Group | Full Year Results |
| FirstGroup | Full Year Results |
| Ted Baker | Trading Statement |
| Crest Nicholson Holdings | Half Year Results |
| Halma | Full Year Results |
| Shield Therapeutics | Full Year Results |
| Trifast | Full Year Results |
| Park Group | Full Year Results |
| Servoca | Half Year Results |
| Norcros | Full Year Results |
| Telecom Plus | Full Year Results |
| Findel | Full Year Results |
| Falkland Island Holdings | Full Year Results |
| CML Microsystems | Full Year Results |
| Paragon Entertainment | Full Year Results |
| Wednesday, June 15 | |
| Oxford Instruments | Full Year Results |
| Castings | Full Year Results |
| Accsys Technologies | Full Year Results |
| Berkeley Group Holdings | Full Year Results |
| Severfield | Full Year Results |
| Jimmy Choo | Trading Statement |
| Thursday, June 16 | |
| WS Atkins | Full Year Results |
| Mulberry Group | Full Year Results |
| Poundland Group | Full Year Results/Trading Statement |
| N Brown Group | Trading Statement |
| Liontrust Asset Management | Full Year Results |
| Darty | Full Year Results |
| Redcentric | Full Year Results |
| Charles Stanley Group | Full Year Results |
| Premier Farnell | Trading Statement |
| Consort Medical | Full Year Results |
| Safestore Holdings | Half Year Results |
| Purplebricks Group | Full Year Results |
| Copyright 2016 Alliance News Limited. All Rights Reserved. | |
18 Nov 2019 10:50
ShoreCap downgrades Consort Medical to 'hold' after all-cash offer from Recipharm
(Sharecast News) - Analysts at ShoreCap downgraded their recommendation for shares of Consort Medical from 'buy' to 'hold' following the recommended cash offer from Recipharm.
Read more